Morgan Stanley : Good timing to anticipate a continuation of the trend
Entry price :
101.76$ | Target : 110.75$ | Stop-loss : 95.35$ | Potential : 8.83%
Morgan Stanley's shares display attractive technical aspects to anticipate a comeback of the underlying trend. Investors have an opportunity to buy the stock and target the $ 110.75.
The group's activity appears highly profitable thanks to its outperforming net margins. Over the last twelve months, the sales forecast has been frequently revised upwards. Analysts have consistently raised their revenue expectations for the company, which provides good prospects for the current and next years in terms of revenue growth. For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner. Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock. The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months. Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases. Historically, the company has been releasing figures that are above expectations.
With relatively low growth outlooks, the group is not among those with the highest revenue growth potential. The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness. The company's enterprise value to sales, at 5.03 times its current sales, is high. The average consensus view of analysts covering the stock has deteriorated over the past four months.
Subsector Other Investment Banking & Brokerage Services
1st jan. Capitalization (M$) Investor Rating
MORGAN STANLEY 49.04% 183 750
ę MarketScreener.com 2021
Disclaimer: The information, charts, data, views, or comments provided by SURPERFORMANCE SAS are intended for investors who have the necessary knowledge and experience to understand and appreciate the information contained within. These items are disseminated for personal reference only. They do not constitute an offer or solicitation to buy or sell financial products or services, nor an investment advice.
The use of the information disseminated takes place under the investor's sole responsibility, without recourse against SURPERFORMANCE SAS. SURPERFORMANCE SAS will not be liable, whether in contract, in tort, under any warranty, for errors, omissions, improper investments, or adverse evolution of markets.
59 651 M
Net income 2021
14 157 M
Net Debt 2021
P/E ratio 2021
EV / Sales 2021
EV / Sales 2022
Nbr of Employees
Upcoming event on MORGAN STANLEY
Number of Analysts
Last Close Price
Average target price
Spread / Average Target